title: Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.
authors.affiliation: Rheumatology Clinic, Bonn-Bad Godesberg, Federal Republic of Germany.
authors.forename: I
authors.initials: I
authors.lastname: Stroehmann
authors.forename: K H
authors.initials: KH
authors.lastname: Giersch
authors.forename: H
authors.initials: H
authors.lastname: Zeidler
authors.forename: P
authors.initials: P
authors.lastname: Münzel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002074:Butanones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D000077430:Nabumetone; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D000077430:Nabumetone